Rehmann Capital Advisory Group’s Dermira, Inc. DERM Stock Holding History

Rehmann Capital Advisory Group’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-250	Closed	-$2.39K	–	2236
2019 Q2	$2.39K	Buy	250 +74	+42%	+$797	﹤0.01%	1739
2019 Q1	$2.38K	Hold	176	–	–	﹤0.01%	1714
2018 Q4	$1.26K	Buy	+176	New	+$1.93K	﹤0.01%	1595

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Rehmann Capital Advisory Group's DERM Position: Q3 2019 in Review

Rehmann Capital Advisory Group sold out of Dermira, Inc. (DERM) in Q3 2019, closing a stake of 250 shares — an estimated $2.39K sold.

Rehmann Capital Advisory Group first reported a position in DERM in Q4 2018 and held it in 3 quarters. The position peaked at $2.39K in Q2 2019. 131 funds tracked by Wall St. Rank hold DERM as of Q3 2019.

Rehmann Capital Advisory Group reported no remaining Dermira, Inc. position as of Q3 2019 after selling out during the quarter.
Rehmann Capital Advisory Group sold 250 Dermira, Inc. shares in Q3 2019, an estimated $2.39K.
Rehmann Capital Advisory Group first reported a position in Dermira, Inc. in Q4 2018 and held it in 3 quarters.
Rehmann Capital Advisory Group's Dermira, Inc. position peaked at $2.39K in Q2 2019.
131 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.